Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of centrally acting muscle relaxants and neuroactive agents. Its structure allows for selective interactions with neurological receptors, making it valuable in creating compounds that modulate neurotransmitter activity. Commonly employed in the preparation of cyclohexane-based chiral building blocks for drug design, especially in treatments targeting neurological and psychiatric disorders. Also utilized in research settings for developing novel analogs with improved bioavailability and receptor specificity.